Hard tissue ablation system

• US 8,114,071 B2
• Filed: 05/29/2007
• Issued: 02/14/2012
• Est. Priority Date: 05/30/2006
• Status: Active Grant

• Current Assignee: ArthroCare Corporation (Smith & Nephew PLC)
• Original Assignee: ArthroCare Corporation (Smith & Nephew PLC)
• Inventors: Woloszko, Jean, Stalder, Kenneth R.
• Primary Examiner(s): COHEN, LEE S
• Application Number:
  US11/754,551
• Publication Number:
  US 20070282323A1
• Time in Patent Office: 1,722 Days
• Field of Search: 606/32, 606/41
• US Class Current: 606/32
• CPC Class Codes: A61B 18/042 using additional gas becoming plasma
• CPC Class Codes: A61B 18/148 having a short, rigid shaft for accessing the inner body transcutaneously, e.g. for neurosurgery or arthroscopy
• CPC Class Codes: A61B 2018/00166 Multiple lumina
• CPC Class Codes: A61B 2018/00565 Bone
• CPC Class Codes: A61B 2018/00577 Ablation
• CPC Class Codes: A61B 2018/1472 for use with liquid electrolyte, e.g. virtual electrodes
• CPC Class Codes: A61B 2218/002 Irrigation
• CPC Class Codes: A61B 2218/007 Aspiration

Abstract

An electrosurgical system and method for treating hard and soft tissues in the body comprises a shaft, a distal end section, an active electrode associated with the distal end section, a first fluid supply adapted to deliver a first electrically conductive fluid to the target site, and a second fluid supply adapted to deliver a second electrically conductive fluid to the active electrode. The system is adapted to treat a wide variety of hard tissues such as, for example, bones, calcified structures, calcified deposits, teeth, plaque, kidney-stones, gall-stones and other types of tissue by generating plasma in the vicinity of the active electrode, and applying the plasma to the tissue or structures.

Claims

1. A method of treating a target structure in a body, comprising:

inserting an active electrode in the vicinity of the target structure in the presence of a first electrically conductive fluid, the first electrically conductive fluid provided from outside of the body;

selectively supplying a second electrically conductive fluid distinct from the first electrically conductive fluid in the vicinity of the active electrode; and

applying electrical energy to the active electrode in the presence of the second conductive fluid sufficient to create a plasma that discharges in the second electrically conductive fluid and treat the target structure, while the first electrically conductive fluid provides a neutralizing barrier to sufficiently dilute the second electrically conductive fluid such that exposure of the second electrically conductive fluid to an untargeted tissue is not harmful.

2. The method of claim 1, wherein the step of applying electrical energy causes at least one of:

molecular dissociation, heating, ablating, coagulating, cutting, removing, and modifying of the target tissue.

3. The method of claim 1, further comprising the step of stopping the supply of the second fluid before treating a soft tissue selected from the group consisting of a ligament, a tendon, a bursa, a muscle, an intervertebral disc and cartilage.

4. The method of claim 3, further comprising the step of applying electrical energy to the active electrode sufficient to discharge a second plasma in the first conductive fluid to treat the soft tissue.

5. The method of claim 1, wherein treating the target structure comprises treating a hard body structure selected from the group consisting of a bone, a calcified tissue, a mineralized tissue, a calcified deposit, kidney stones, gall stones, tartar deposits, a tooth, and plaque.

6. The method of claim 1, wherein treating the target structure comprises treating a mineralized deposit in the body.

7. The method of claim 1, comprising treating a target tissue selected from the group consisting of an articular joint and an acromion.

8. The method of claim 1, comprising treating a soft tissue subsequent to treating a hard tissue.

9. The method of claim 1, wherein supplying the second electrically conductive fluid comprises supplying sodium bicarbonate solution.

10. The method of claim 1, wherein the plasma discharge from the second electrically conductive fluid is particularly effective at ablating bone tissue.

11. The method of claim 1, wherein the first electrically conductive fluid comprises a first indicator that effects the color of the plasma from said first fluid.

12. The method of claim 11, wherein the first indicator comprises potassium chloride.

13. The method of claim 1, comprising stopping the flow of the second electrically conductive fluid to the active electrode site when treating soft tissue.

14. A method of treating a target structure in a body, comprising:

delivering to the target structure a first electrically conductive fluid supplied from outside of the body;

forming plasma from a second electrically conductive fluid that is chemically distinct from the first electrically conductive fluid while the first electrically conductive fluid provides a neutralizing barrier to sufficiently dilute the second fluid such that exposure of the second electrically conductive fluid to an untargeted tissue is not harmful; and

treating the structure with the plasma.

15. The method of claim 14, wherein the first electrically conductive fluid is selected from the group consisting of:

isotonic saline, hypertonic saline, hypotonic saline, and Ringer'"'"'s lactate solution.

16. The method of claim 14, wherein the second electrically conductive fluid comprises sodium bicarbonate.

17. The method of claim 14, wherein treating the target structure comprises treating a hard body structure selected from the group consisting of a bone, a calcified tissue, a mineralized tissue, a calcified deposit, kidney stones, gall stones, tartar deposits, a tooth, and plaque.

18. A method of modifying a structure in a body, comprising:

identifying a body structure in a patient;

delivering a first electrically conductive fluid from outside the body to the area surrounding and including the body structure;

selecting a second electrically conductive fluid effective in treating said body structure and that is chemically distinct from the first electrically conductive fluid,

directing the second electrically conductive fluid to an active electrode in the vicinity of the body structure; and

applying a radio-frequency voltage to the active electrode in the presence of the second electrically conductive fluid sufficient to create a plasma that discharges in the second electrically conductive fluid and such that the body structure is modified while the first electrically conductive fluid provides a neutralizing barrier to sufficiently dilute the second electrically conductive fluid such that exposure of the second electrically conductive fluid to an untargeted tissue is not harmful.

19. The method of claim 18, wherein identifying the structure comprises identifying a hard body structure selected from the group consisting of a bone, a calcified tissue, a mineralized tissue, a calcified deposit, kidney stones, gall stones, tartar deposits, a tooth, and plaque.

20. The method of claim 18, wherein identifying the structure comprises identifying a soft tissue selected from the group consisting of a ligament, a tendon, a muscle, cartilage, and an intervertebral disc.

21. The method of claim 18, wherein delivering first electrically conductive fluid comprises flooding the structure with an electrically conductive fluid selected from the group consisting of:

isotonic saline, hypertonic saline, hypotonic saline, and Ringer'"'"'s lactate solution.

22. The method of claim 18, wherein directing a second electrically conductive fluid comprises directing a solution of sodium bicarbonate to the active electrode.

23. The method of claim 18, wherein the body structure is modified only where the second electrically conductive fluid is sufficiently concentrated while mixed with the first electrically conductive fluid.